Thrombolysis for acute ischaemic stroke: core nursing requirements (Q35126046)

6 August 2017

1 reference

title

Thrombolysis for acute ischaemic stroke: core nursing requirements (English)

1 reference

6 August 2017

1 reference

Karen Innes

1

1 reference

6 August 2017

IST-3 Stroke Nurse Collaborative Group

2

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743488

1 January 2024

publication date

1 April 2003

1 reference

6 August 2017

10 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743488

full work available at URL

1 January 2024

http://www.magonlinelibrary.com/doi/pdf/10.12968/bjon.2003.12.7.11262

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

British Journal of Nursing

1 January 2024

published in

1 reference

6 August 2017

12

1 reference

6 August 2017

7

1 reference

6 August 2017

416-424

1 reference

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

6 August 2017

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Hea

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Dynamics of bed use in accommodating emergency admissions: stochastic simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoi

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Hypertension and its treatment in the NINDS rt-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Conditions that mimic stroke in the emergency department. Implications for acute stroke trials

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Thrombolytic treatment for acute ischaemic stroke: consent can be ethical

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Thrombolytic therapy with streptokinase in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

The high cost of not funding stroke research: a comparison with heart disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2003.12.7.11262

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

21 January 2018

8

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 January 2024

9

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 January 2024

14

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

The Quarterly Journal of Medicine

1 January 2024

30

88

727

Morris AD

1995

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

Revisiting the Glasgow Coma Scale and Coma Score

1 January 2024

38

1 reference

https://api.crossref.org/works/10.12968/BJON.2003.12.7.11262

1 January 2024

Identifiers

0 references

1 reference